A5
A58.F Anthem Inc
- Market cap
- EUR 82.6B
- P/E
- 18.9x
- P/B
- 2.04x
- ROE
- 13.7%
- Dividend yield
- 1.63%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is A58.F undervalued?
Graham numberA58.F trades 30.7% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Anthem Inc fundamental analysis
No fundamental analysis for Anthem Inc yet.
Anthem Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Anthem Inc
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and othe…
Full company profileAnthem Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Anthem Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 84.9B | 90.0B | 92.1B | 104B | 122B | 139B | 157B | 171B | 177B | 199B | 203B |
| Gross Profit | 18.0B | 17.8B | 20.2B | 22.4B | - | - | - | - | - | - | - |
| Operating Income | 5.28B | 4.99B | 5.82B | 6.73B | - | - | - | - | - | - | - |
| Net Income | 2.47B | 3.84B | 3.75B | 4.81B | 4.57B | 6.10B | 6.03B | 5.99B | 5.98B | 5.66B | 6.12B |
| EPS | - | 15 | 15 | 19 | 19 | 25 | 25 | 26 | 26 | 26 | 28 |
| Balance Sheet | |||||||||||
| Total Assets | 65.1B | 70.5B | 71.6B | 77.5B | 86.6B | 97.3B | 103B | 109B | 117B | 121B | 128B |
| Total Liabilities | 40.0B | 44.0B | 43.0B | 45.7B | 53.4B | 61.2B | 66.4B | 69.5B | 75.5B | 77.5B | 83.0B |
| Shareholders' Equity | 25.1B | 26.5B | 28.5B | 31.7B | 33.2B | 36.1B | 36.3B | 39.3B | 41.3B | 43.9B | 44.7B |
| Cash & Short-term Investments | 4.08B | 3.61B | 3.93B | 4.94B | 5.74B | 4.88B | 7.39B | 6.53B | 8.29B | 9.49B | 10.3B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 3.27B | 4.19B | 3.83B | 6.06B | 10.7B | 8.36B | 8.40B | 9.51B | 5.81B | 4.29B | 10.0B |
| Capital Expenditure | 584M | 791M | 1.21B | 1.08B | 1.02B | 1.09B | 1.15B | 1.27B | 1.26B | 1.12B | 1.05B |
| Free Cash Flow | - | 3.39B | 2.62B | 4.98B | 9.67B | 7.28B | 7.25B | 8.25B | 4.55B | 3.17B | 8.96B |
| Ratios | |||||||||||
| ROE | 9.8% | 14.5% | 13.1% | 15.2% | 13.8% | 16.9% | 16.6% | 15.2% | 14.5% | 12.9% | 13.7% |
| ROA | 3.8% | 5.4% | 5.2% | 6.2% | 5.3% | 6.3% | 5.9% | 5.5% | 5.1% | 4.7% | 4.8% |
| Net Profit Margin | 2.9% | 4.3% | 4.1% | 4.6% | 3.8% | 4.4% | 3.8% | 3.5% | 3.4% | 2.8% | 3.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Anthem Inc dividends
- Dividend yield
- 1.63%
- Forward dividend
- 6.13 EUR
- Payout ratio
- 27.0%
- Ex-dividend date
- Dec 4, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 1.53B | 6.93 | 27.0% |
| 2024 | USD 1.51B | 6.63 | 25.2% |
| 2023 | USD 1.35B | 5.81 | 22.6% |
| 2022 | USD 1.23B | 5.16 | 20.4% |
| 2021 | USD 1.10B | 4.55 | 18.1% |
| 2020 | USD 954M | 3.89 | 20.9% |
| 2019 | USD 818M | 3.23 | 17.0% |
| 2018 | USD 776M | 3.01 | 20.7% |
| 2017 | USD 705M | 2.75 | 18.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Anthem Inc
- Insiders 0.19%
- Institutions 94.61%
- Public & others 5.21%
- Shares outstanding 216M
- Free float 216M
Anthem Inc company profile
- Company name
- Anthem Inc
- Ticker
- A58.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 96,129
- Fiscal year end
- December
- Address
- 220 Virginia Avenue, Indianapolis, IN, United States, 46204
- Phone
- 833 401 1577
- Website
- elevancehealth.com
About Anthem Inc
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Anthem Inc management
10- Ms. Gail Koziara BoudreauxPresident, CEO & Director · born 1961
- Mr. Mark Bradley KayeExecutive VP & CFO · born 1980
- Mr. Peter David Haytaian Esq.Special Advisor · born 1970
- Mr. Charles Morgan Kendrick Jr.EVP and President of Commercial & Specialty Health Benefits · born 1966
- Ms. Felicia Farr NorwoodExecutive VP & Chief Health Benefits Officer · born 1960
- Mr. Scott Wayne AnglinSVP, Treasurer & Chief Investment Officer
- Mr. Ronald William PenczekSenior VP, Controller & Chief Accounting Officer · born 1965
- Mr. Nathan Allen RichVice President of Investor Relations
- Ms. Erin M. WesslingExecutive VP & Chief Legal Officer · born 1978
- Ms. Julie GoonSenior Vice President of Public Affairs